WCLC 2021
IASLC 2021 WORLD CONFERENCE ON LUNG CANCER
September 8-14, 2021 | Virtual
Advances in the treatment and diagnosis for MPM and thymoma
Biomarker testing to aid in lung cancer diagnosis
A milestone in biomarker testing and therapies for lung cancer
Combination of durvalumab, tremelimumab and chemotherapy as a potential new first-line mNSCLC treatment option
Neoadjuvant nivolumab plus chemotherapy shows long-term survival in stage IIIA NSCLC patients: NADIM study
DFS improvement with atezolizumab versus BSC after adjuvant chemotherapy: Phase 3 IMpower010 trial